MBX
MBX Biosciences, Inc.
57.72
+1.39 (+2.47%)
52w low 23.07
72.64 high
69.9% of range
MBX · 6M
—
O--
H--
L--
C--
Chg--
Gap--
Vol--
×avg--
σ--
SMA20--
SMA50--
SMA200--
RSI--
SPY--
DD--
Bench--
Sig--
Hist--
pinned · Esc to release
hover · click to pin · ← → step · drag to zoom · shift-drag to measure
SMA 20SMA 50
—Context
- Move across the chart.
Events in view
| Date | Kind | Event | Source |
|---|---|---|---|
| 2026-11-09 | filing | 8-K: results of operations (earnings); Reg FD disclosure | SEC EDGAR |
| 2026-11-09 | filing | 10-Q (quarterly report) | SEC EDGAR |
| 2026-10-22 | filing | 8-K: officer / director change | SEC EDGAR |
| 2026-08-27 | filing | 8-K: Reg FD disclosure; other events | SEC EDGAR |
| 2026-08-06 | filing | 8-K: results of operations (earnings); Reg FD disclosure; other events | SEC EDGAR |
| 2026-08-06 | filing | 10-Q (quarterly report) | SEC EDGAR |
| 2026-07-13 | filing | 8-K: officer / director change | SEC EDGAR |
| 2026-06-12 | filing | 8-K: Reg FD disclosure; other events | SEC EDGAR |
| 2026-06-05 | filing | 8-K: officer / director change; shareholder vote | SEC EDGAR |
| 2026-05-11 | filing | 8-K: Reg FD disclosure; other events | SEC EDGAR |
| 2026-05-08 | filing | DEFA14A (proxy material) | SEC EDGAR |
| 2026-05-07 | filing | 10-Q (quarterly report) | SEC EDGAR |
| 2026-05-07 | filing | 8-K: results of operations (earnings) | SEC EDGAR |
Performance
1D
+2.47%
5D
+9.98%
1M
+10.96%
3M
-13.81%
6M
+53.92%
YTD
+83.01%
1Y
+131.71%
2Y
+145.62%
3Y
--
5Y
--
MAX
+122.17%
Period
+79.70%
High
72.64
Low
28.00
Ann Vol
52.27%
Sharpe
1.33
Max DD
-31.46%
ATR (14)
3.72